Skip to main content
Premium Trial:

Request an Annual Quote

Genescient Teams with Kronos on Alzheimer’s Research

NEW YORK (GenomeWeb News) – Genescient and Kronos Science Laboratory will collaborate to identify genes that may be involved in Alzheimer’s disease, Genescient said today.

The company said it hopes to use Kronos’ Alzheimer's disease data set to target genes that previously have not been recognized as linked to the disease.

Irvine, Calif.-based Genescient said it has identified over 750 unique human genomic pathways that may be associated with age-related diseases such as cardiovascular disease, type II diabetes, and other chronic diseases. The company said its technology enables scientists to “probe the entire biochemical machinery behind chronic diseases.”

Financial and other terms of the collaboration were not disclosed.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.